Delivery Order SPE2DB24D1034-SPE2DB25FVYK7

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.50 firm fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.50 firm-fixed-price delivery order is for the provision of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2023. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,211.25 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a completion date of January 12, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09, UEI: KABZK8W6PQT3) is for the supply of NAFTIN 1% GEL 40GM pharmaceutical products to the Defense Logistics Agency (DLA). The $17,759.35 firm fixed price delivery order has a completion date of May 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of NAFTIN 1% GEL 40GM pharmaceutical products. The Firm Fixed Price Delivery Order, valued at $1,792.90, has a performance period through May 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,477.36, is for the delivery of 4560955312 NAFTIN 1% GEL 40GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,822.38 firm fixed-price delivery order is for the supply of NAFTIN 2% GEL 60GM, a topical antifungal medication. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,054.98, is for the delivery of the drug product NAFTIN 1% GEL 40GM. It is a firm fixed-price delivery order contract with an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant...
This federal contract award, valued at $4,220.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a performance period through June 28, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,429.62 firm fixed-price delivery order is for the supply of NAFTIN 2% Gel, a topical antifungal medication. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FVYK7
    Delivery Order

This federal contract award, SPE2DB24D1034|SPE2DB25FVYK7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,997.11 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a medical product, with a completion date of November 12, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:33 PM